MET
Price
$95.67Alerts
Change
-$1.93 (-1.98%)
Updated
Nov 20 closing price
Capitalization
62.45B
74 days until earnings call
Intraday BUY SELL Signals
MFC
Price
$40.89Alerts
Change
-$1.32 (-3.13%)
Updated
Nov 20 closing price
Capitalization
71.64B
88 days until earnings call
Intraday BUY SELL Signals
PRU
Price
$117.73Alerts
Change
-$2.57 (-2.14%)
Updated
Nov 20 closing price
Capitalization
41.14B
80 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MET or MFC or PRU

MET vs MFC vs PRU Comparison Chart in %
View a ticker or compare two or three
A.I.Advisor
Oct 20, 2026

Which Stock Would AI Choose? MetLife (MET) vs. Manulife Financial (MFC) vs. Prudential Financial (PRU) Stock Comparison

Key Takeaways

  • MET (MetLife) has posted the strongest recent earnings momentum, with double-digit growth in adjusted earnings per share (EPS, or profit divided by shares outstanding) and an adjusted return on equity (ROE, a measure of profitability) near the top of its target range.
  • MFC (Manulife Financial) is being driven by robust Asia growth and a growing wealth-and-asset-management franchise, though North American retail flows have been a near-term headwind.
  • PRU (Prudential Financial) offers the highest dividend yield but faces a Japan sales suspension and an ongoing portfolio-simplification effort that weighs on near-term earnings.
  • All three are life and health insurers, but their geographic exposure differs sharply: MetLife is globally diversified, Manulife skews toward Asia and Canada, and Prudential is concentrated in the U.S. and Japan.
  • Valuation and analyst sentiment diverge, with MetLife carrying richer earnings multiples and Prudential trading at a lower multiple but with a more cautious consensus rating.

Introduction

Life insurers can look similar on the surface, yet their growth drivers, geographic exposure, and risk profiles differ considerably. This stock comparison examines three large-cap names—MET, MFC, and PRU—to help traders and investors assess relative performance and market positioning. The comparison is relevant for those weighing diversified global insurers against Asia-centric franchises, as well as income-focused investors evaluating dividend yields against growth momentum. By reviewing recent earnings, catalysts, and valuation sensitivity side by side, readers can better understand where each company stands in the current market environment.

MET Overview and Recent Performance

MetLife, Inc. (MET) is a global financial services company providing insurance, annuities, employee benefits, and asset management. In recent quarters, the company has delivered broad-based growth across its segments under its "New Frontier" strategy. Adjusted earnings rose by a double-digit percentage year over year in the first half of 2026, supported by favorable underwriting, higher investment income, and volume growth in businesses such as Group Benefits, Asia, and Europe, the Middle East, and Africa (EMEA). Adjusted ROE has reached the upper end of the company's 15%–17% target range, while the direct expense ratio has improved.

MetLife's stock has rallied strongly over recent months, with a year-to-date gain above 20% that has lifted shares toward record territory. This relative strength reflects improving mortality trends in its group life business and sustained international momentum, particularly in Japan and Korea. On valuation, MetLife trades at a higher price-to-earnings (P/E) ratio than many insurance peers, which some analysts view as a premium justified by execution, while others see as leaving less margin for error.

MFC Overview and Recent Performance

Manulife Financial Corporation (MFC) is a Canadian-headquartered insurer and wealth manager operating across Asia, Canada, and the United States (through its John Hancock unit), alongside a global wealth and asset management (Global WAM) division. Recent results have been anchored by Asia, where core earnings grew more than 20% year over year, supported by strong sales in Hong Kong, Japan, and Singapore. New business value (NBV, a measure of the profitability of newly written policies) and new business contractual service margin (CSM, the expected future profit from insurance contracts) both advanced.

Momentum in Manulife's shares has been more measured than MetLife's, with a single-digit to low-teens year-to-date gain in recent weeks. Near-term headwinds include net outflows in active mutual funds across North American retail channels and less favorable group-insurance claims experience in Canada. Offsetting these pressures, the company maintains a strong capital position, reflected in a Life Insurance Capital Adequacy Test (LICAT) ratio well above regulatory requirements, and has returned significant capital through dividends and buybacks. Manulife has also been recognized for its leadership in applying artificial intelligence across its operations.

PRU Overview and Recent Performance

Prudential Financial, Inc. (PRU) is a U.S.-based financial services firm with life insurance, annuities, retirement, and asset management operations, including its PGIM investment management arm and roughly $1.6 trillion in assets under management (AUM, or total assets it manages on behalf of clients). Its two largest markets are the United States and Japan. Recent adjusted operating earnings have grown, aided by higher net investment spreads and new business growth, though results have been tempered by higher expenses.

Prudential's relative performance has been more subdued, with the stock trading roughly flat year to date in recent weeks. The key near-term overhang is a sales suspension in its Japan operations, which the company has said will reduce pretax adjusted operating income, with a broader impact expected across 2026 and 2027. Prudential is also simplifying its portfolio, agreeing to sell its Brazil and Mexico life businesses. These moves support a narrower, more focused franchise but constrain near-term earnings. Prudential offers the highest dividend yield of the three, near 4.8%, supported by a moderate payout ratio.

Trending AI Robots

For traders seeking a systematic edge, Tickeron's Trending AI Robots page showcases a curated selection of AI-powered trading bots. Tickeron offers hundreds of AI trading bots that trade thousands of different tickers, but only those best suited to current market conditions earn a place in this section. Each bot has its own trading style, strategy, timeframe, performance statistics, and set of tickers it trades, with many demonstrating notable win rates and trade frequency across different horizons. Browsing the Trending AI Robots section can help you see how automated strategies are positioning in names like MET, MFC, and PRU and identify the tools that align with your approach.

Head-to-Head Comparison

The three insurers diverge most clearly on geography and growth profile. MetLife is the most globally diversified, spreading risk across the Americas, Asia, and EMEA, which has translated into consistent earnings momentum and the strongest recent share-price appreciation. Manulife offers a distinct tilt toward high-growth Asian insurance markets and a sizeable wealth-management business, giving it a differentiated growth runway, though its near-term flows have been uneven. Prudential is the most U.S.-centric of the group and carries a legacy variable-annuity runoff, alongside a Japan business currently under regulatory-driven sales restrictions.

On valuation, MetLife trades at the richest earnings multiple of the three, reflecting investor confidence in its execution but leaving less cushion if results disappoint. Prudential trades at the lowest P/E ratio and offers the highest dividend yield, appealing to income investors but with a consensus analyst rating skewed toward "Hold" and a visible earnings drag from Japan. Manulife sits in the middle, balancing growth in Asia with capital returns and a strong balance sheet.

Risk factors also differ. MetLife faces sensitivity to investment spreads and mortality trends; Manulife is exposed to currency movements and Canadian group-insurance claims; Prudential faces regulatory risk in Japan and credit-cycle exposure through its private credit operations. For momentum-oriented investors, MetLife has shown the most consistent trend; for income and value, Prudential's yield and lower multiple stand out; for growth and diversification, Manulife's Asian franchise is the central differentiator.

Tickeron AI Verdict

Based on observable factors such as trend consistency, earnings momentum, and relative positioning, Tickeron's AI would likely favor MET among the three in the current environment. MetLife combines the most consistent recent uptrend, broad-based earnings growth, and an improving ROE, characteristics that quantitative models tend to reward. Manulife (MFC) presents a compelling growth story but with less uniform momentum, while Prudential (PRU) offers value and income but carries near-term earnings headwinds that may temper trend signals. This assessment is probabilistic and reflects current conditions rather than a definitive prediction.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for MET with price predictions
Nov 20, 2026

Momentum Indicator for MET turns negative, indicating new downward trend

MET saw its Momentum Indicator move below the 0 level on November 18, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned negative. In 52 of the 84 cases, the stock moved further down in the following days. The odds of a decline are at 62%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for MET moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In 21 of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at 45%.

The Moving Average Convergence Divergence Histogram (MACD) for MET turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 31 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 58%.

MET moved below its 50-day moving average on November 19, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MET declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 50%.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +1.25% 3-day Advance, the price is estimated to grow further. Considering data from situations where MET advanced for three days, in 229 of 346 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

MET may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 167 of 283 cases where MET Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 22 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 62, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. MET’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MET's P/B Ratio (2.276) is slightly higher than the industry average of (1.337). P/E Ratio (18.683) is within average values for comparable stocks, (19.773). Projected Growth (PEG Ratio) (0.506) is also within normal values, averaging (0.463). Dividend Yield (0.024) settles around the average of (0.047) among similar stocks. P/S Ratio (0.824) is also within normal values, averaging (1.303).

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for MFC with price predictions
Nov 20, 2026

MFC in downward trend: price dove below 50-day moving average on November 16, 2026

MFC moved below its 50-day moving average on November 16, 2026 date and that indicates a change from an upward trend to a downward trend. In 17 of 34 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 50%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MFC as a result. In 32 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 42%.

The Moving Average Convergence Divergence Histogram (MACD) for MFC turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 19 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 40%.

The 10-day moving average for MFC crossed bearishly below the 50-day moving average on November 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 6 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 38%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MFC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 49%.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for MFC's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +0.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where MFC advanced for three days, in 225 of 350 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.

MFC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 207 of 355 cases where MFC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 58%.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 4 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 62, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. MFC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 53 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.537) is normal, around the industry mean (1.337). P/E Ratio (11.686) is within average values for comparable stocks, (19.773). Projected Growth (PEG Ratio) (0.876) is also within normal values, averaging (0.463). Dividend Yield (0.031) settles around the average of (0.047) among similar stocks. P/S Ratio (1.780) is also within normal values, averaging (1.303).

The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for PRU with price predictions
Nov 20, 2026

PRU's RSI Indicator recovers from overbought zone

The 10-day RSI Indicator for PRU moved out of overbought territory on November 05, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 instances where the indicator moved out of the overbought zone. In 23 of the 39 cases the stock moved lower in the days that followed. This puts the odds of a move down at 59%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PRU as a result. In 52 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 57%.

The Moving Average Convergence Divergence Histogram (MACD) for PRU turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 26 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 57%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.

PRU broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

PRU moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for PRU crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 73%.

Following a +3.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where PRU advanced for three days, in 210 of 353 cases, the price rose further within the following month. The odds of a continued upward trend are 59%.

The Aroon Indicator entered an Uptrend today. In 177 of 313 cases where PRU Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 30 (best 1 - 100 worst), indicating outstanding price growth. PRU’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.303) is normal, around the industry mean (1.337). P/E Ratio (10.752) is within average values for comparable stocks, (19.773). Projected Growth (PEG Ratio) (0.674) is also within normal values, averaging (0.463). Dividend Yield (0.047) settles around the average of (0.047) among similar stocks. P/S Ratio (0.632) is also within normal values, averaging (1.303).

The Tickeron Profit vs. Risk Rating rating for this company is 44 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 62, placing this stock slightly better than average.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
MET vs MFC vs PRU: Fundamental Ratings
MET
MFC
PRU
OUTLOOK RATING
1..100
767581
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
53
Fair valued
32
Undervalued
PROFIT vs RISK RATING
1..100
22444
SMR RATING
1..100
99100100
PRICE GROWTH RATING
1..100
424630
P/E GROWTH RATING
1..100
157777
SEASONALITY SCORE
1..100
505050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRU's Valuation (32) in the Financial Conglomerates industry is in the same range as MFC (53) in the Life Or Health Insurance industry, and is in the same range as MET (55) in the Life Or Health Insurance industry. This means that PRU's stock grew similarly to MFC’s and similarly to MET’s over the last 12 months.

MFC's Profit vs Risk Rating (4) in the Life Or Health Insurance industry is in the same range as MET (22) in the Life Or Health Insurance industry, and is somewhat better than the same rating for PRU (44) in the Financial Conglomerates industry. This means that MFC's stock grew similarly to MET’s and somewhat faster than PRU’s over the last 12 months.

MET's SMR Rating (99) in the Life Or Health Insurance industry is in the same range as MFC (100) in the Life Or Health Insurance industry, and is in the same range as PRU (100) in the Financial Conglomerates industry. This means that MET's stock grew similarly to MFC’s and similarly to PRU’s over the last 12 months.

PRU's Price Growth Rating (30) in the Financial Conglomerates industry is in the same range as MET (42) in the Life Or Health Insurance industry, and is in the same range as MFC (46) in the Life Or Health Insurance industry. This means that PRU's stock grew similarly to MET’s and similarly to MFC’s over the last 12 months.

MET's P/E Growth Rating (15) in the Life Or Health Insurance industry is somewhat better than the same rating for PRU (77) in the Financial Conglomerates industry, and is somewhat better than the same rating for MFC (77) in the Life Or Health Insurance industry. This means that MET's stock grew somewhat faster than PRU’s and somewhat faster than MFC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
METMFCPRU
RSI
ODDS (%)
Bearish Trend 2 days ago
45%
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
59%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
59%
Momentum
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
42%
Bearish Trend 2 days ago
57%
MACD
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
40%
Bearish Trend 2 days ago
57%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
44%
Bullish Trend 2 days ago
58%
Advances
ODDS (%)
Bullish Trend 11 days ago
66%
Bullish Trend 11 days ago
64%
Bullish Trend 12 days ago
59%
Declines
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
49%
Bearish Trend 2 days ago
54%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
59%
Aroon
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
57%
COMPARISON
Comparison
Nov 22, 2026
Stock price -- (MET: $95.67, MFC: $40.89, PRU: $117.73)
Brand notoriety: MET and PRU are notable and MFC is not notable
The three companies represent the Life/Health Insurance industry
Current volume relative to the 65-day Moving Average: MET: 133%, MFC: 133%, PRU: 120%
Market capitalization -- MET: $62.45B, MFC: $71.64B, PRU: $41.14B
$MET is valued at $62.45B, while MFC has a market capitalization of $71.64B, and PRU's market capitalization is $41.14B. The market cap for tickers in this @Life/Health Insurance ranges from $228.36K to $140.68B. The average market capitalization across the @Life/Health Insurance industry is $18.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MET’s FA Score shows that 2 FA rating(s) are green while MFC’s FA Score has 1 green FA rating(s), and PRU’s FA Score reflects 2 green FA rating(s).

  • MET’s FA Score: 2 green, 3 red.
  • MFC’s FA Score: 1 green, 4 red.
  • PRU’s FA Score: 2 green, 3 red.
According to our system of comparison, MET is a better buy in the long-term than PRU, which in turn is a better option than MFC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MET’s TA Score shows that 4 TA indicator(s) are bullish while MFC’s TA Score has 5 bullish TA indicator(s), and PRU’s TA Score reflects 5 bullish TA indicator(s).

  • MET’s TA Score: 4 bullish, 5 bearish.
  • MFC’s TA Score: 5 bullish, 5 bearish.
  • PRU’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, MFC is a better buy in the short-term than MET and PRU.

Price Growth

MET (@Life/Health Insurance) experienced а -6.80% price change this week, while MFC (@Life/Health Insurance) price change was -6.44% , and PRU (@Life/Health Insurance) price fluctuated -4.71% for the same time period.

The average weekly price growth across all stocks in the @Life/Health Insurance industry was -6.67%. For the same industry, the average monthly price growth was -7.44%, and the average quarterly price growth was -9.12%.

Reported Earning Dates

MET is expected to report earnings on Feb 03, 2027.

MFC is expected to report earnings on Feb 17, 2027.

PRU is expected to report earnings on Feb 09, 2027.

Industries' Descriptions

@Life/Health Insurance (-6.67% weekly)

Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

MET and

Correlation & Price change

A.I.dvisor indicates that over the last year, MET has been closely correlated with PRU. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if MET jumps, then PRU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MET
1D Price
Change %
MET100%
-1.98%
PRU - MET
72%
Closely correlated
-2.14%
LNC - MET
69%
Closely correlated
-3.34%
CNO - MET
66%
Closely correlated
-1.93%
PRI - MET
57%
Loosely correlated
-0.26%
JXN - MET
56%
Loosely correlated
-1.88%
More

MFC and

Correlation & Price change

A.I.dvisor indicates that over the last year, MFC has been loosely correlated with MET. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if MFC jumps, then MET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MFC
1D Price
Change %
MFC100%
-2.34%
MET - MFC
58%
Loosely correlated
-1.98%
PRU - MFC
56%
Loosely correlated
-2.14%
PUK - MFC
56%
Loosely correlated
-2.38%
LNC - MFC
48%
Loosely correlated
-3.34%
GL - MFC
44%
Loosely correlated
-1.26%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XERS16.970.35
+2.11%
Xeris Biopharma Holdings
BSAC30.04-0.22
-0.73%
Banco Santander-Chile
KOP29.04-1.28
-4.22%
Koppers Holdings
MPU4.50-0.26
-5.46%
Mega Matrix Inc
HTLM0.94-0.15
-14.13%
HomesToLife Ltd